Younghoon Cho
Plastic Surgery · Houston, TXNPI 1427137694
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $812,113 of the $1,223,079 with a category attached, or 66.4%. AbbVie accounts for 71.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $366,222 and has fallen 70.9% since, to $106,506 in 2025. Among plastic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,235 payments — averaging $990.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$877K
- Galderma Laboratories, L.p.$332K
- Merz North America, Inc.$12K
- TELA Bio, Inc.$516
- Tepha Inc$447
- Revance Therapeutics, Inc.$397
- plus $583 from 4 others
Across 13 payments — averaging $8686.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$113K
What the payments were for
- Consulting fees$276,77523%
- Speaking & faculty fees$812,11366%
- Travel & lodging$82,3617%
- Food & beverage$27,7552%
- Education$21,3742%
- Gifts$2,7000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 827 | $877,118 |
| Galderma Laboratories, L.p. | 329 | $332,466 |
| Merz North America, Inc. | 57 | $11,552 |
| TELA Bio, Inc. | 4 | $516 |
| Tepha Inc | 4 | $447 |
| Revance Therapeutics, Inc. | 6 | $397 |
| Mentor Worldwide LLC | 3 | $231 |
| Pacira Pharmaceuticals Incorporated | 3 | $138 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $121 |
| Davol Inc. | 1 | $94 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$441,837
- NATRELLE SALINE-FILLED BREAST IMPLANTS$19,460
- BOTOX COSMETIC$13,614
- XEOMIN$7,779
- NATRELLE$4,260
- KYBELLA$1,950
- REVOLVE$1,619
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,420
- GalaFLEX$436
- OviTex 2S$321
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$177
- DAXXIFY$170
- MENTOR MemoryGel Resterilizable Gel Sizer$149
- ARTOURA Breast Tissue Expander$149
- DYSPORT$115
- DAXI$112
- EXPAREL$103
How this compares
$1,223,079 in reported general payments places this provider in the 95th percentile of 337 plastic surgery providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 28 | $603 |
| Doxycycline Hyclate | 23 | $305 |
| Gabapentin | 28 | $77 |
| Tramadol Hcl | 20 | $66 |
| Diazepam | 13 | $57 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Houston
- David AdelmanHouston$405K
- Warren EllsworthHouston$284K
- Camille CashHouston$212K
- Robert YarishHouston$180K
- Alexander MericliHouston$125K
- Kristy HamiltonHouston$70K
- Jenny NguyenHouston$45K
- Patrick HsuHouston$34K
- Anthony EchoHouston$27K
- Matthew GreivesHouston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.